Results 71 to 80 of about 54,214 (96)

CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.

Cancer Research, 2011
Hongyan Wang, Chun-Peng Zhang, A. Rorick, Dayong Wu, Ming Chiu, J. Thomas-Ahner, Zhong Chen, Hongyan Chen, S. Clinton, K. Chan, Qianben Wang   +10 more
semanticscholar   +1 more source

A phase 2 study of temsirolimus (CCI‐779) in patients with soft tissue sarcomas

Cancer, 2011
S. Okuno, H. Bailey, M. Mahoney, D. Adkins, W. Maples, T. Fitch, D. Ettinger, C. Erlichman, J. Sarkaria   +8 more
semanticscholar   +1 more source

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.

Endocrine-Related Cancer, 2001
Ker Yu, L. Toral‐Barza, C. Discafani, Weiguo Zhang, J. Skotnicki, P. Frost, James Joseph Gibbons   +6 more
semanticscholar   +1 more source

Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks

Clinical Cancer Research, 2010
J. Sarkaria, E. Galanis, Wenting Wu, A. Dietz, T. Kaufmann, M. Gustafson, P. Brown, J. Uhm, R. Rao, L. Doyle, C. Giannini, K. Jaeckle, J. Buckner   +12 more
semanticscholar   +1 more source

Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

Blood, 2010
K. Friedbichler, M. Kerenyi, B. Kovacic, Geqiang Li, Andrea Hoelbl, Saliha Yahiaoui, V. Sexl, E. Müllner, Sabine Fajmann, S. Cerny‐Reiterer, P. Valent, H. Beug, F. Gouilleux, K. Bunting, R. Moriggl   +14 more
semanticscholar   +1 more source

Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma

Molecular Cancer Therapeutics, 2009
O. Ekshyyan, Y. Rong, Xiaohua Rong, K. Pattani, F. Abreo, G. Caldito, John Kai Siung Chang, F. Ampil, J. Glass, C. Nathan   +9 more
semanticscholar   +1 more source

The chemokine receptor antagonist, TAK‐779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function

British Journal of Pharmacology, 2009
Jia Ni, Yi-na Zhu, Xiang-Gen Zhong, Yu Ding, Li-fei Hou, Xiankun Tong, Wei Tang, S. Ono, Yi-fu Yang, Jian-Ping Zuo   +9 more
semanticscholar   +1 more source

Asma

Open Respiratory Archives
doaj   +1 more source

Circulación pulmonar

Open Respiratory Archives
doaj   +1 more source

Sueño y ventilación

Open Respiratory Archives
doaj   +1 more source